acth (4-10) has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biebermann, H; Grüters, A; Krude, H; Mullis, PE; Schnabel, D; Tansek, MZ; Theunissen, P | 1 |
| Benedict, C; Born, J; Fehm, HL; Hallschmid, M; Kern, W; Perras, B; Schultes, B | 1 |
2 other study(ies) available for acth (4-10) and Obesity
| Article | Year |
|---|---|
Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10.
Topics: Adrenocorticotropic Hormone; Basal Metabolism; Body Weight; Child, Preschool; DNA Mutational Analysis; Genotype; Hair Color; Humans; Infant; Infant, Newborn; Obesity; Peptide Fragments; Phenotype; Pro-Opiomelanocortin; Thyroid Gland; Thyroid Hormones | 2003 |
Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders.
Topics: Adipose Tissue; Administration, Intranasal; Adrenocorticotropic Hormone; Body Weight; Central Nervous System; Cognition Disorders; Female; Humans; Hypoglycemic Agents; Insulin; Male; Melanocyte-Stimulating Hormones; Metabolic Diseases; Neuropeptides; Nootropic Agents; Obesity; Peptide Fragments; Receptors, Melanocortin; Satiety Response; Signal Transduction | 2008 |